Filing Details
- Accession Number:
- 0001209191-18-042304
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-07-11 16:04:14
- Reporting Period:
- 2018-07-09
- Accepted Time:
- 2018-07-11 16:04:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1367920 | Concert Pharmaceuticals Inc. | CNCE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1594774 | Nancy Stuart | C/O Concert Pharmaceuticals, Inc. 99 Hayden Avenue, Suite 500 Lexington MA 02421 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-07-09 | 5,291 | $17.56 | 116,085 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-07-10 | 26,127 | $17.94 | 89,958 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on March 19, 2018.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.6995 to $18.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
Billionaire Hedge Funds
